Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Researchers have found in a new study that semaglutide could provide cardiovascular benefits to high-risk patients even ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests. The drug, ...

Denmark’s Novo Nordisk has presented data at the European Congress of Obesity (ECO) showing that Wegovy (semaglutide ...

Novo Nordisk’s Wegovy (semaglutide injection) 2.4mg has demonstrated early protection against heart disease, according to new ...

New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

Weight loss jabs like Wegovy combat several diverse conditions, from heart attacks to cancer, and the explanation may be that ...

Landmark' data has revealed a popular weight loss medicine slashes the risk of heart attack, stroke or heart disease death ...

People taking Zepbound, lost nearly 50% more weight than those using rival Wegovy in the first head-to-head study of the ...

The drug, which contains the active ingredient semaglutide, works by reducing food cravings ... This suggests the drug’s protection against heart disease is not only related to its effect on driving ...